Khatri, Bhupendra and Barkhof, Frederik and Comi, Giancarlo and Hartung, Hans-Peter and Kappos, Ludwig and Montalban, Xavier and Pelletier, Jean and Stites, Tracy and Wu, Stacy and Holdbrook, Fred and Zhang-Auberson, Lixin and Francis, Gordon and Cohen, Jeffrey A. and Transforms Study Group, . (2011) Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis : a randomised extension of the TRANSFORMS study. The Lancet neurology, Vol. 10, H. 6. pp. 520-529.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6006991
Downloads: Statistics Overview
Abstract
In a 12-month phase 3 study in patients with relapsing-remitting multiple sclerosis (RRMS), TRANSFORMS, fingolimod showed greater efficacy on relapse rates and MRI outcomes compared with interferon beta-1a. We had two aims in our extension: to compare year 2 with year 1 in the switched patients to assess the effect of a change from interferon beta-1a to fingolimod, and to compare over 24 months the treatment groups as originally randomised to assess the effect of delaying the start of treatment with fingolimod.
| Faculties and Departments: | 03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos) 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Neurologie > Neuroimmunologie (Kappos) |
|---|---|
| UniBasel Contributors: | Kappos, Ludwig |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Elsevier |
| ISSN: | 1474-4465 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Identification Number: | |
| Last Modified: | 06 Dec 2013 09:36 |
| Deposited On: | 06 Dec 2013 09:36 |
Repository Staff Only: item control page